| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0021-9150(95)05551-7 |
| P698 | PubMed publication ID | 7575778 |
| P2093 | author name string | M Suzuki | |
| S Fukuhara | |||
| S Nomura | |||
| Y Miyazaki | |||
| H Kido | |||
| H Kagawa | |||
| T Miyake | |||
| K Katsura | |||
| G L Xie | |||
| P433 | issue | 2 | |
| P304 | page(s) | 235-240 | |
| P577 | publication date | 1995-08-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus | |
| P478 | volume | 116 |
| Q44317901 | A new method to evaluate spontaneous platelet aggregation in type 2 diabetes by Cellfacts |
| Q36035053 | Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. |
| Q42129359 | Association between vascular access failure and microparticles in hemodialysis patients |
| Q33313270 | Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy |
| Q36551157 | Cellular connections, microenvironment and brain angiogenesis in diabetes: Lost communication signals in the post-stroke period |
| Q88426782 | Cholesterol and the journey of extracellular vesicles |
| Q73835373 | Circulating monocytes in patients with diabetes mellitus, arterial disease, and increased CD14 expression |
| Q33338927 | Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia |
| Q46167362 | Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients |
| Q53592726 | Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus. |
| Q44083900 | Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus |
| Q44434979 | Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus |
| Q33813731 | Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy |
| Q42121320 | Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus |
| Q57074152 | Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study) |
| Q37246729 | Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia |
| Q27016553 | Emerging roles for platelets as immune and inflammatory cells |
| Q37801877 | Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Rito |
| Q39115035 | Extracellular vesicles in coronary artery disease. |
| Q64915816 | Extracellular vesicles in type 2 diabetes mellitus: key roles in pathogenesis, complications, and therapy. |
| Q34496416 | Function and clinical significance of platelet-derived microparticles |
| Q47435929 | Generation of platelet-derived microparticles in patients undergoing cardiac surgery is not affected by complement activation |
| Q39099983 | Glucose and angiotensin II-derived endothelial extracellular vesicles regulate endothelial dysfunction via ERK1/2 activation |
| Q45236205 | Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects. |
| Q35688330 | High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes |
| Q35755253 | Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy |
| Q34238659 | Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia |
| Q47152819 | Liraglutide attenuates atherosclerosis via inhibiting ER-induced macrophage derived microvesicles production in T2DM rats |
| Q46426269 | Losartan and simvastatin inhibit platelet activation in hypertensive patients |
| Q85225978 | Macroprolactinemia, like hyperprolactinemia, may promote platelet activation |
| Q38215838 | Mechanism of antiplatelet action of hypolipidemic, antidiabetic and antihypertensive drugs by PPAR activation: PPAR agonists: new antiplatelet agents. |
| Q80931100 | Microparticles and type 2 diabetes |
| Q39603636 | Microparticles in tumor progression. |
| Q46541119 | Microparticles released by human neutrophils adhere to erythrocytes in the presence of complement |
| Q36745194 | Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets |
| Q36175435 | Microvesicles/exosomes as potential novel biomarkers of metabolic diseases |
| Q37273154 | Microvesicles: potential markers and mediators of endothelial dysfunction |
| Q36232987 | Minireview: Emerging Roles for Extracellular Vesicles in Diabetes and Related Metabolic Disorders |
| Q37387105 | Modulation of monocyte-endothelial cell interactions by platelet microparticles |
| Q36977373 | Molecular basis for a link between complement and the vascular complications of diabetes |
| Q43919826 | Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia |
| Q91979008 | Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients |
| Q44941582 | Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: therapeutic effects by cilostazol and potentiation by dipyridamole |
| Q38362628 | Platelet transfusion - the new immunology of an old therapy |
| Q34708937 | Platelet transfusions: Impact on hemostasis, thrombosis, inflammation and clinical outcomes |
| Q42420507 | Platelet-derived miR-92a downregulates cysteine protease inhibitor cystatin C in type II diabetic lower limb ischemia |
| Q73815958 | Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines |
| Q73828192 | Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism |
| Q36717080 | Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets |
| Q73068632 | Relationship between platelet activation and cytokines in systemic inflammatory response syndrome patients with hematological malignancies |
| Q28069254 | Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis |
| Q74261220 | Significance of chemokines and activated platelets in patients with diabetes |
| Q92535745 | The Contrasting Role of Extracellular Vesicles in Vascular Inflammation and Tissue Repair |
| Q36564652 | The Impact of Lipoprotein-Associated Oxidative Stress on Cell-Specific Microvesicle Release in Patients with Familial Hypercholesterolemia. |
| Q47159100 | The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles |
| Q41549617 | The impact of hyperglycemia and hyperlipidemia on plasma P-selectin and platelet markers after ischemic stroke |
| Q27003277 | The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance |
| Q37798968 | The role of calpain in diabetes-associated platelet hyperactivation. |
| Q26801407 | The role of platelets in the recruitment of leukocytes during vascular disease |
| Q44794739 | Young male smokers have altered platelets and endothelium that precedes atherosclerosis. |
Search more.